THOMAS J KIPPS

LA JOLLA, CA NPI 1306861950

General Payments — all program years on this page

$208,179.69

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 189
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $6,409.34 across 18 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Consulting Fee $4,210.003
Travel and Lodging $1,744.247
Food and Beverage $424.817
Education $30.291

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Merck Sharp & Dohme Corporation $2,536.8011
BeiGene USA, Inc. $2,250.001
ABBVIE INC. $1,428.323
Apellis Pharmaceuticals, Inc. $144.272
E.R. Squibb & Sons, L.L.C. $49.951

By program year

Program yearAmountRecords
2018 $51,289.3751
2019 $61,081.8755
2020 $27,778.5716
2021 $18,200.2313
2022 $18,480.0010
2023 $24,940.3126
2024 $6,409.3418

Records — PY2024 (18)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1101328728 E.R. Squibb & Sons, L.L.C. $49.95 12/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1103136263 ABBVIE INC. $1,350.00 07/19/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1104079730 ABBVIE INC. $15.93 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104191810 ABBVIE INC. $62.39 07/10/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1120849888 BeiGene USA, Inc. $2,250.00 04/04/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1141562064 Merck Sharp & Dohme LLC $39.98 10/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141562066 Merck Sharp & Dohme LLC $785.04 10/17/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1141562068 Merck Sharp & Dohme LLC $39.99 10/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141562070 Merck Sharp & Dohme LLC $8.00 10/17/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1141562072 Merck Sharp & Dohme LLC $304.88 10/18/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1141562180 Merck Sharp & Dohme LLC $304.88 10/17/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1141562182 Merck Sharp & Dohme LLC $64.99 10/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141694572 Merck Sharp & Dohme LLC $610.00 11/11/2024 Consulting Fee Undisputed 01/23/2026 View at CMS
1141824165 Merck Sharp & Dohme LLC $99.99 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141824167 Merck Sharp & Dohme LLC $131.55 10/18/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1141824293 Merck Sharp & Dohme LLC $147.50 10/17/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1154030680 Apellis Pharmaceuticals, Inc. $113.98 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154030682 Apellis Pharmaceuticals, Inc. $30.29 06/10/2024 Education Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.